SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Matritech (NASDAQ - NMPS)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: eugenic1 who wrote (25)5/19/1996 1:59:00 PM
From: Fred McGriff   of 849
 
Matritech will become an industry leader in non-invasive cancer testing and as an extension of MIT and John Hopkins they have an R & D system that is the envy of the medical industry. 3-5 years from now this will be a $70 stock. It's only been recently that they have started attracting the institutional investors. The speculators may bail on the "news" but this will only be used as a buying opportunity for the long term holders who understand the company and the patents they hold worldwide on the NMP process. I will be watching and waiting to buy more on any significant pullback... which are fewer and farther between.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News